Dupont Capital Management’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,208
Closed -$214K 1456
2022
Q3
$214K Sell
10,208
-3,999
-28% -$83.8K 0.01% 856
2022
Q2
$441K Buy
14,207
+8,080
+132% +$251K 0.02% 763
2022
Q1
$252K Sell
6,127
-542
-8% -$22.3K 0.01% 974
2021
Q4
$290K Sell
6,669
-4,689
-41% -$204K 0.01% 984
2021
Q3
$569K Sell
11,358
-2,597
-19% -$130K 0.02% 804
2021
Q2
$879K Hold
13,955
0.02% 690
2021
Q1
$1.3M Sell
13,955
-1,307
-9% -$121K 0.03% 495
2020
Q4
$1.37M Buy
15,262
+5,834
+62% +$523K 0.03% 447
2020
Q3
$974K Buy
9,428
+2,157
+30% +$223K 0.02% 525
2020
Q2
$575K Sell
7,271
-4,484
-38% -$355K 0.01% 708
2020
Q1
$680K Sell
11,755
-16,231
-58% -$939K 0.02% 569
2019
Q4
$1.51M Hold
27,986
0.03% 430
2019
Q3
$1.46M Buy
27,986
+18,475
+194% +$966K 0.03% 421
2019
Q2
$459K Sell
9,511
-4,431
-32% -$214K 0.01% 825
2019
Q1
$704K Sell
13,942
-705
-5% -$35.6K 0.02% 640
2018
Q4
$868K Sell
14,647
-19,092
-57% -$1.13M 0.02% 572
2018
Q3
$2.22M Buy
33,739
+19,486
+137% +$1.28M 0.05% 354
2018
Q2
$720K Hold
14,253
0.02% 630
2018
Q1
$750K Sell
14,253
-11,240
-44% -$591K 0.02% 593
2017
Q4
$1.19M Buy
+25,493
New +$1.19M 0.03% 483
2015
Q2
Sell
-24,661
Closed -$709K 579
2015
Q1
$709K Hold
24,661
0.01% 484
2014
Q4
$672K Hold
24,661
0.01% 525
2014
Q3
$526K Hold
24,661
0.01% 555
2014
Q2
$554K Hold
24,661
0.01% 572
2014
Q1
$623K Sell
24,661
-38,493
-61% -$972K 0.01% 572
2013
Q4
$1.45M Sell
63,154
-9,782
-13% -$225K 0.03% 432
2013
Q3
$1.39M Buy
72,936
+17,213
+31% +$328K 0.03% 440
2013
Q2
$804K Buy
+55,723
New +$804K 0.02% 494